Is Wegovy Similar to Ozempic?

Wegovy and Ozempic are both GLP-1 medications but are used for different indications and have distinct coverage considerations.

Overview of Wegovy and Ozempic

Wegovy and Ozempic are both medications that belong to the GLP-1 receptor agonist class. They contain the same active ingredient, semaglutide, but are approved for different uses. Wegovy is specifically indicated for chronic weight management in adults with obesity or overweight, while Ozempic is primarily indicated for the treatment of type 2 diabetes.

Coverage and Indications

Wegovy carries an FDA indication to reduce cardiovascular risk in adults with established cardiovascular disease and obesity or overweight, which can be a covered medical indication. In contrast, Ozempic is covered more readily for type 2 diabetes. Therefore, if a diabetes diagnosis applies, requests for Ozempic should be framed around that condition. This distinction can affect insurance coverage and prior authorization requirements.

Cost and Access

Both medications may have different pricing and access pathways. Wegovy is available through cash self-pay programs, while savings cards may work with commercial insurance but generally exclude government plans like Medicare and Medicaid. It's important to check with your insurance provider for specific coverage details regarding each medication.